Clinical Trial Update: CK0801 for Treatment of Aplastic Anemia [Phase 2]

View source ↗

Summary

This clinical trial update indicates CK0801 for the treatment of aplastic anemia is in Phase 2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CK0801

Snippet

Sponsor: Cellenkos, Inc. | Conditions: Aplastic Anemia | Phase 2 | Status: NOT_YET_RECRUITING